Daily cannabis news
po.tc tracks the practical cannabis stories that shape operators, investors, regulators, and suppliers: medical access, licensing, imports, tax exposure, retail structure, and the policy decisions behind them.
Latest articles
Washington has put a $400 annual fee increase into effect for standard cannabis producers, processors, and retailers, raising the renewal cost to $1,781 and adding a new fixed expense for businesses that already hold licenses.
Read moreFrance’s last missing reimbursement text for medical cannabis has been sent for legal review, a step that brings the country closer to a permanent but tightly restricted treatment market.
Read moreMinnesota’s latest cannabis licensing data shows the state still has only a dozen issued adult-use retailer licenses, a slow pace that matters because the current 150-store cap will stay in place until at least mid-2027.
Read moreNews feed
Washington has raised the annual state license fee for standard cannabis producers, processors, and retailers to $1,781 from $1,381. The increase took effect in practice on July 1, 2026, when the Washington State Liquor and...
Read moreFrance’s last missing text on medical cannabis reimbursement has moved into legal review. Trade reporting says the decree was submitted to the Conseil d’État on 2026-07-02, which is the formal review stage before a French decree...
Read moreMinnesota has issued 12 cannabis retailer licenses out of 150 available retailer slots, according to the state’s July 6 licensing snapshot. That is an 8.0 percent fill rate for the license category that matters most to the...
Read moreKentucky’s medical cannabis program has reached the point where paperwork matters less than doors, inventory and distance.
Read moreCalifornia is moving on a narrow cannabis cultivation rule with broad practical effects. The state’s Department of Cannabis Control is taking written comments through July 27 and will hold a public hearing on July 28 on a...
Read moreUruguay’s 2025 export tables now show something unusually concentrated. In the country’s recorded category for medical-cannabis medicines and active pharmaceutical ingredients, or APIs, Brazil was the only destination.
Read moreUkraine’s medical-cannabis rollout has crossed the line from policy to operation. On 15 June, the State Expert Center said it had received 49 registration applications for cannabis-based medicines and active pharmaceutical...
Read more